Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: J. Nelson who wrote (93311)	10/10/2001 8:40:36 AM
From: Joe Copia	Read Replies (1) \| Respond to of 150070

Business Editors/Medical Writers VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct. 10, 2001--Rocky Mountain Ginseng, Inc.'s (Pink Sheets:RMGS) China operation, Rocky Mountain (Fuzhou) Drug Co., Ltd., announced in Fuzhou it will open its third company-owned store on November 1, 2001. Upon making the announcement, Assistant General Manager Xiao Chen, stated that over the past several weeks marketing staff have been assessing possible locations for future company-owned stores in Fuzhou and Quanzhou in the Fujian province. "The third store is at a corner location in much sought after location in a densely populated upper middle income residential area in central Fuzhou," Mr. Chen stated. "Decoration of the new store will get underway this week." Experience to date shows that company-owned stores are very profitable. Profit margins average 100 percent and all transactions are in cash which greatly reduces the amount of operating capital required to carry out this program. Mr. Chen concluded that the company intends to open 20 new stores before Chinese Spring festival next February. ABOUT ROCKY MOUNTAIN GINSENG, INC. Rocky Mountain Ginseng, Inc.'s head office is located in British Columbia, Canada. The Company exports American ginseng to its facilities in Fuzhou, China where it manufactures and processes American ginseng products. Rocky Mountain Ginseng, Inc. holds exclusive world processing and distribution rights to several innovative value added ginseng products developed in North America. Rocky Mountain Ginseng, Inc. purchased a drug manufacturing facility in February 1999, now known as Rocky Mountain (Fuzhou) Drug Co. Ltd. This acquisition included all necessary drug and hygiene licenses allowing the Company to import, export, manufacture and distribute ginseng products in all provinces of China. The company has also recently obtained the right to establish company-owned stores and franchised stores anywhere in China. The Company currently produces traditional ginseng products for the Chinese Market, which includes selling to its wholesale customers and through its retail stores, with the Chinese factory employing 42 people in processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly owned Canadian Company in the Fujian province. Certain statements contained herein constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business and financing, business trends, and future operating revenues and expenses. Although the Company believes that the statements are reasonable, it can give no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the Company or contained in this profile-research report, contain no guarantee of future performance, and that the actual result may differ materially from those set forth in the forward-looking statements. Differences in results can be caused by various factors including, but not limited to, the Company's ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. --30--ATR/se* CONTACT: PMR & Associates, LLC Pat Rost, 760/942-0015 PMRandCo@aol.com or Rocky Mountain (Fuzhou) Drug Co. Ltd. Brian A. Hodge, (86) 591/379-7969 rockymt@public.fz.fj.cn or www.RMGGInvestor.com